OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 99 filers reported holding OPHTHOTECH CORP in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,000 | -50.0% | 683 | -37.2% | 0.00% | – |
Q4 2018 | $2,000 | +100.0% | 1,087 | +103.6% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 534 | +9.2% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 489 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | -83.3% | 489 | -74.9% | 0.00% | – |
Q4 2017 | $6,000 | +200.0% | 1,949 | +167.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 730 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | -33.3% | 730 | -13.0% | 0.00% | – |
Q1 2017 | $3,000 | -99.0% | 839 | -98.7% | 0.00% | – |
Q4 2016 | $307,000 | -46.2% | 63,645 | +414.6% | 0.00% | – |
Q3 2016 | $571,000 | -34.0% | 12,368 | -27.0% | 0.00% | -100.0% |
Q2 2016 | $865,000 | -81.1% | 16,949 | -84.4% | 0.00% | -66.7% |
Q1 2016 | $4,588,000 | +39.5% | 108,521 | +159.0% | 0.00% | +50.0% |
Q4 2015 | $3,290,000 | +1512.7% | 41,892 | +731.9% | 0.00% | – |
Q3 2015 | $204,000 | -96.2% | 5,036 | -95.1% | 0.00% | -100.0% |
Q2 2015 | $5,304,000 | +12528.6% | 101,880 | +11220.0% | 0.00% | – |
Q1 2015 | $42,000 | +121.1% | 900 | +106.9% | 0.00% | – |
Q4 2014 | $19,000 | – | 435 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |